S. Ananth results 20
· Newest (Page 1/1, per page 25)
Author: S. Ananth ×Clear All Filters
Search Results
Influence of genetic polymorphisms on gefitinib pharmacokinetics and adverse drug reactions in non-small cell lung cancer patientsNARA Subscribed
Gefitinib is a first-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) used in the treatment of non-small cell lung cancer (NSCLC). It is metabolized extensively in the liver by enzymes encoded by CYP3A4 , CYP2D6, and CYP3A5 and is the substrate of membrane transporters including ABCB1 and ABCG2 . Evidence shows that single-nucleotide polymorphisms (SNPs) in these metabolizing and transporting...
Imaging and power generation strategies for chandrayaan-1NARA Subscribed
Previous1Next